To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Refreshed 30 min ago

Introduced 2025-01-23Topic: health care

Summary

No summary yet. The official text is available on Congress.gov.

Date	Chamber	Action	Status effect
2025-01-23	House	Referred to the House Committee on Energy and Commerce.	refer
2025-01-23		Introduced in House	introduce
2025-01-23		Introduced in House	introduce